Skip to main content

Day: March 24, 2022

GameOn Partners With Tetavi to Launch Innovative NFT Music Discovery Game

VANCOUVER, British Columbia, March 24, 2022 (GLOBE NEWSWIRE) — GameOn Entertainment Technologies Inc. (“GameOn” or the “Company”) (CSE: GET) (OTCQB: GMETF), a leading NFT game technology company partnered with the world’s biggest IPs to launch, operate and monetize NFT-based games, has today announced a partnership with immersive content pioneer, Tetavi, for a first-of-its-kind NFT music discovery game. Established in 2016, Tetavi is a new media, technology company and the leader in volumetric video capture. Tetavi uses cutting-edge volumetric video technology and proprietary algorithms built on thousands of hours of machine learning to create next generation photorealistic digital content and immersive experiences. Their mission is to enable connection, self-expression, and creativity in the Metaverse and Web3. Through the partnership,...

Continue reading

ValOre Expands Pedra Branca Inferred Mineral Resource by 106% to 2.2 Million Ounces at 1.08 g/t 2PGE+Au

VANCOUVER, British Columbia, March 24, 2022 (GLOBE NEWSWIRE) — ValOre Metals Corp. (“ValOre”; TSX‐V: VO; OTC: KVLQF; Frankfurt: KEQ0, “the Company”) today reported an updated independent National Instrument 43-101 (“NI 43-101”) inferred mineral resource estimate for ValOre’s 100%-owned Pedra Branca Platinum Group Elements (“PGE”, “2PGE+Au”) Project (“Pedra Branca”) in northeastern Brazil. ValOre’s CEO, Jim Paterson stated, “We are very pleased to announce the doubling of ValOre’s Pedra Branca inferred mineral resource estimate, which was expanded to 2.2 million ounces of palladium, platinum, and gold at 1.08 g/t 2PGE+Au. Several of the zones which form part of the resource estimate remain wide open for expansion in future drill programs. ValOre’s technical team has demonstrated their ability to expand known resource zones and to...

Continue reading

ProMIS Neurosciences to Present at the 10th Annual Neurodegenerative Drug Development Summit

TORONTO, Ontario and CAMBRIDGE, MA , March 24, 2022 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today that it will be presenting at the upcoming 10th Annual Neurodegenerative Drug Development Summit, to be held in Boston, MA, March 28-30, 2022. ProMIS Chief Scientific Officer, Dr. Neil Cashman, will deliver an oral presentation entitled: “Abeta oligomers in Alzheimer Disease: Target Engagement and Target Distraction”, on Tuesday, March 29, 2022, at 3 PM local time at the Boston Park Plaza Hotel. Much scientific data has implicated misfolded oligomers as the toxic molecular species of amyloid beta (Abeta)...

Continue reading

View Smart Windows Selected for Healthpeak’s Third Large-Scale Life Sciences Development in San Diego

Sorrento Gateway is the latest large-scale project in San Diego with View Smart Windows, following installations at Callan Ridge and The BoardwalkSorrento Gateway in San Diego View announced its Smart Windows will be installed at Sorrento Gateway, a life science building in San Diego under development by Healthpeak Properties, Inc.SAN DIEGO and MILPITAS, Calif., March 24, 2022 (GLOBE NEWSWIRE) — View, Inc. (NASDAQ: VIEW) (“View”), the leader in smart building technologies, announced its Smart Windows will be installed at Sorrento Gateway, a five-story, 163,000-square-foot life science building under development by Healthpeak Properties, Inc. (“Healthpeak”) in conjunction with Project Management Advisors, Inc. (“PMA”), Healthpeak’s representative responsible for providing project management services. Located in San Diego’s...

Continue reading

Green Thumb Industries Continues Community Investment Initiatives with Donation to Olive-Harvey College in Chicago

CHICAGO and VANCOUVER, British Columbia, March 24, 2022 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE dispensaries, is expanding its partnership with Olive-Harvey College by donating $200,000 to support the school’s cannabis education program. The program provides training, scholarships, equipment, staffing and industry access to help create a more diverse workforce within the cannabis industry. Olive-Harvey is a community college on the southeast side of Chicago and is part of the City Colleges of Chicago. The donation was made on behalf of Green Thumb’s Growing for Good social impact program and fulfills the Company’s Social Equity Inclusion plan requirement for Illinois’ early approval adult-use cultivation...

Continue reading

Akouos to Participate in Upcoming March Virtual Investor Conferences

BOSTON, March 24, 2022 (GLOBE NEWSWIRE) — Akouos, Inc. (“Akouos”) (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, today announced that Manny Simons, Ph.D., M.B.A., co-founder, president, and chief executive officer will participate in two upcoming virtual investor conferences in March:H.C. Wainwright Gene Therapy and Gene Editing ConferencePre-recorded presentation available for on-demand viewing on Wednesday, March 30 at 7:00 a.m. EST. Panel discussion titled “Unlocking the path to hearing restoration with gene therapy” on Wednesday, March 30 at 1:00 p.m. EST.Guggenheim Genomic Medicines & Rare Disease Day on Thursday, March 31.Webcasts of the H.C. Wainwright presentation and panel discussion will...

Continue reading

Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer

ACTON, Mass., March 24, 2022 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”, “the Company”), a late-stage, pre-revenue diagnostics company focused on developing cost-effective, rapid, near-patient products for triage and monitoring of disease progression, today announced that Kenneth Fisher, CPA, has joined the Company as Chief Financial Officer (CFO), effective March 23, 2022. He will report to Neil Dey, Chief Executive Officer. Gordon Kinder resigned his position as CFO to pursue other professional interests. Mr. Fisher is an accomplished financial professional and Certified Public Accountant. He has enjoyed a 20-year, multi-faceted career in the public accounting and financial services industries. Most recently, he was a senior executive with a $6.6 billion NASDAQ-listed financial institution. Mr. Fisher...

Continue reading

XPO Logistics Named a 2021 Supplier of the Year by General Motors

GREENWICH, Conn., March 24, 2022 (GLOBE NEWSWIRE) — XPO Logistics, Inc. (NYSE: XPO), a leading provider of freight transportation services, has been named a Supplier of the Year by General Motors in the transportation category. XPO is among a prestigious group of suppliers recognized by GM executives for outstanding performance in 2021. This is the fourth consecutive year that XPO has been honored as a GM Supplier of the Year. The two companies collaborate on the continuous improvement of GM’s aftermarket parts distribution channel, with a focus on on-time delivery and cost efficiency. Drew Wilkerson, XPO’s president of North American transportation, said, “We’re proud to support General Motors by optimizing the flow of aftermarket parts with an engineered transportation network. Our technology maintains constant visibility of...

Continue reading

Sabre Gold Drills 74.1 g/t Gold

Image 1 Copperstone Underground Drill Stations P2E & P2F Panel 2 in Zone D – Looking SouthwestVANCOUVER, British Columbia, March 24, 2022 (GLOBE NEWSWIRE) — Sabre Gold Mines Corp. (TSX: SGLD, OTCQB: SGLDF) (“Sabre Gold” or the “Company”) is pleased to announce continued positive underground drilling results at its 100% owned Copperstone gold project located in Arizona, United States. Mike Maslowski, Vice President of Technical Services and Exploration of Sabre Gold stated: “Results from what was known as the northern edge of the D zone continue to return high grade gold intercepts. The gold grades and continuity of the intercepts indicates the D Zone may extend further north. We are planning future underground development to establish additional drill stations to the north to test for the extension of this zone.” Drilling...

Continue reading

HOOKIPA Reports Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Outlook

Lead oncology candidate HB-200 demonstrated high antigen-specific T cell responses and encouraging anti-tumor activity in heavily pre-treated head and neck cancer patientsHOOKIPA received FDA Fast Track designation and advanced HB-200 to Phase 2 trial in combination with pembrolizumab, with data anticipated in H2 2022HOOKIPA and Gilead agreed to advance partnered HIV program, triggering $54 million commitment from GileadStrong 2021 year-end pro forma cash position of $156.9 million when giving effect to payments received in Q1 2022 from Gilead transaction and proceeds of $75 million public follow-on offeringNEW YORK and VIENNA, Austria, March 24, 2022 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.